Michael Peluso, MD
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Interleukin-15 to Promote Post-ART Control of HIV (NCT07145164) | Michael Peluso, MD | 2025-08-19 |
| Anti-SARS-CoV-2 Monoclonal Antibodies for Long COVID (COVID-19) (NCT05877508) | Michael Peluso, MD | 2023-08-01 |
Track Michael Peluso, MD automatically
Every clearance here is in the API, with alerts when new ones post.